Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

NCT01215955 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1117

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin lispro
DRUG: Glargine

Sponsor

Eli Lilly and Company